An altered relationship of influenza vaccine-specific IgG responses with T cell immunity occurs with aging in humans

Clinical Immunology

Volumn 147, Issue 2, 2013, Pages 79-88

  Kang, Ki Soo ^a,b   Lee, Naeun ^a   Shin, Min Sun ^a   Kim, Sang Doo ^a,c   Yu, Yinyi ^a   Mohanty, Subhasis ^a   Belshe, Robert B ^d   Montgomery, Ruth R ^a   Shaw, Albert C ^a   Kang, Insoo ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Jeju National University School of Medicine   (South Korea)

^c Sungkyunkwan University   (South Korea)

^d SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Human; Humoral response; Influenza vaccine; T cells

Indexed keywords

CD45RA ANTIGEN; GAMMA INTERFERON; HEMAGGLUTININ; IMMUNOGLOBULIN G; INFLUENZA VACCINE; INTERLEUKIN 17; INTERLEUKIN 7 RECEPTOR ALPHA;

2009 H1N1 INFLUENZA; ADULT; AGED; AGING; ANTIBODY TITER; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL SURVIVAL; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EFFECTOR CELL; FEMALE; HEMAGGLUTINATION INHIBITION TEST; HUMAN; HUMAN CELL; IMMUNOGLOBULIN BLOOD LEVEL; INFLUENZA A (H3N2); INFLUENZA B; INFLUENZA VIRUS A H1N1; LYMPHOCYTE PROLIFERATION; MALE; MEMORY T LYMPHOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SERUM; T LYMPHOCYTE SUBPOPULATION;

ADULT; AGED; AGING; ANTIBODIES, VIRAL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; HEMAGGLUTININS; HUMANS; IMMUNOGLOBULIN G; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; INTERFERON-GAMMA; INTERLEUKIN-17; MALE; YOUNG ADULT;

EID: 84876321281     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2013.02.022     Document Type: Article

References (40)

1. Miller R.A. Aging and immune function. Fundamental Immunology 1999, 947-966. Lippincott-Raven, Philadelphia. W.E. Paul (Ed.).
2. Lee N., Shin M.S., Kang I. T-cell biology in aging, with a focus on lung disease. J. Gerontol. A Biol. Sci. Med. Sci. 2012, 67:254-263.
3. Dorshkind K., Montecino-Rodriguez E., Signer R.A. The ageing immune system: is it ever too old to become young again?. Nat. Rev. Immunol. 2009, 9:57-62.
4. Kogut I., Scholz J.L., Cancro M.P., Cambier J.C. B cell maintenance and function in aging. Semin. Immunol. 2012, 24:342-349.
5. McElhaney J.E., Effros R.B. Immunosenescence: what does it mean to health outcomes in older adults?. Curr. Opin. Immunol. 2009, 21:418-424.
6. Goronzy J.J., Weyand C.M. T cell development and receptor diversity during aging. Curr. Opin. Immunol. 2005, 17:468-475.
7. Akbar A.N., Fletcher J.M. Memory T cell homeostasis and senescence during aging. Curr. Opin. Immunol. 2005, 17:480-485.
8. Effros R.B., Cai Z., Linton P.J. CD8 T cells and aging. Crit. Rev. Immunol. 2003, 23:45-64.
9. Nikolich-Zugich J. Ageing and life-long maintenance of T-cell subsets in the face of latent persistent infections. Nat. Rev. Immunol. 2008, 8:512-522.
10. Lee J.S., Lee W.W., Kim S.H., Kang Y., Lee N., Shin M.S., Kang S.W., Kang I. Age-associated alteration in naive and memory Th17 cell response in humans. Clin. Immunol. 2011, 140:84-91.
11. Sallusto F., Lenig D., Forster R., Lipp M., Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999, 401:708-712.
12. Kim H.R., Hwang K.A., Park S.H., Kang I. IL-7 and IL-15: biology and roles in T-Cell immunity in health and disease. Crit. Rev. Immunol. 2008, 28:325-339.
13. Kim H.R., Hong M.S., Dan J.M., Kang I. Altered IL-7R{alpha} expression with aging and the potential implications of IL-7 therapy on CD8+ T-cell immune responses. Blood 2006, 107:2855-2862.
14. Hong M.S., Dan J.M., Choi J.Y., Kang I. Age-associated changes in the frequency of naive, memory and effector CD8+ T cells. Mech. Ageing Dev. 2004, 125:615-618.
15. Murphy K.M., Stockinger B. Effector T cell plasticity: flexibility in the face of changing circumstances. Nat. Immunol. 2010, 11:674-680.
16. Zhu J., Paul W.E. Heterogeneity and plasticity of T helper cells. Cell Res. 2010, 20:4-12.
17. Doreau A., Belot A., Bastid J., Riche B., Trescol-Biemont M.C., Ranchin B., Fabien N., Cochat P., Pouteil-Noble C., Trolliet P., Durieu I., Tebib J., Kassai B., Ansieau S., Puisieux A., Eliaou J.F., Bonnefoy-Berard N. Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus. Nat. Immunol. 2009, 10:778-785.
18. Stevens T.L., Bossie A., Sanders V.M., Fernandez-Botran R., Coffman R.L., Mosmann T.R., Vitetta E.S. Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells. Nature 1988, 334:255-258.
19. Thompson W.W., Shay D.K., Weintraub E., Brammer L., Cox N., Anderson L.J., Fukuda K. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003, 289:179-186.
20. Goodwin K., Viboud C., Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 2006, 24:1159-1169.
21. Chen W.H., Kozlovsky B.F., Effros R.B., Grubeck-Loebenstein B., Edelman R., Sztein M.B. Vaccination in the elderly: an immunological perspective. Trends Immunol. 2009, 30:351-359.
22. McElhaney J.E. Influenza vaccine responses in older adults. Ageing Res. Rev. 2011, 10:379-388.
23. Murasko D.M., Bernstein E.D., Gardner E.M., Gross P., Munk G., Dran S., Abrutyn E. Role of humoral and cell-mediated immunity in protection from influenza disease after immunization of healthy elderly. Exp. Gerontol. 2002, 37:427-439.
24. Panda A., Qian F., Mohanty S., van Duin D., Newman F.K., Zhang L., Chen S., Towle V., Belshe R.B., Fikrig E., Allore H.G., Montgomery R.R., Shaw A.C. Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response. J. Immunol. 2010, 184:2518-2527.
25. Zhou X., McElhaney J.E. Age-related changes in memory and effector T cells responding to influenza A/H3N2 and pandemic A/H1N1 strains in humans. Vaccine 2011, 29:2169-2177.
26. Kang I., Hong M.S., Nolasco H., Park S.H., Dan J.M., Choi J.Y., Craft J. Age-associated change in the frequency of memory CD4+ T cells impairs long term CD4+ T cell responses to influenza vaccine. J. Immunol. 2004, 173:673-681.
27. Valenzuela H.F., Effros R.B. Divergent telomerase and CD28 expression patterns in human CD4 and CD8 T cells following repeated encounters with the same antigenic stimulus. Clin. Immunol. 2002, 105:117-125.
28. Goronzy J.J., Fulbright J.W., Crowson C.S., Poland G.A., O'Fallon W.M., Weyand C.M. Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals. J. Virol. 2001, 75:12182-12187.
29. Saurwein-Teissl M., Lung T.L., Marx F., Gschosser C., Asch E., Blasko I., Parson W., Bock G., Schonitzer D., Trannoy E., Grubeck-Loebenstein B. Lack of antibody production following immunization in old age: association with CD8(+)CD28(-) T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines. J. Immunol. 2002, 168:5893-5899.
30. Hwang K.A., Kim H.R., Kang I. Aging and human CD4(+) regulatory T cells. Mech. Ageing Dev. 2009, 130:509-517.
31. Lee W.W., Shin M.S., Kang Y., Lee N., Jeon S., Kang I. The relationship of cytomegalovirus (CMV) infection with circulatory IFN-alpha levels and IL-7 receptor alpha expression on CD8(+) T cells in human aging. Cytokine 2012, 58:332-335. (Epub ahead of print).
32. Geginat J., Lanzavecchia A., Sallusto F. Proliferation and differentiation potential of human CD8+ memory T-cell subsets in response to antigen or homeostatic cytokines. Blood 2003, 101:4260-4266.
33. Nakaya H.I., Wrammert J., Lee E.K., Racioppi L., Marie-Kunze S., Haining W.N., Means A.R., Kasturi S.P., Khan N., Li G.M., McCausland M., Kanchan V., Kokko K.E., Li S., Elbein R., Mehta A.K., Aderem A., Subbarao K., Ahmed R., Pulendran B. Systems biology of vaccination for seasonal influenza in humans. Nat. Immunol. 2011, 12:786-795.
34. Gibson K.L., Wu Y.C., Barnett Y., Duggan O., Vaughan R., Kondeatis E., Nilsson B.O., Wikby A., Kipling D., Dunn-Walters D.K. B-cell diversity decreases in old age and is correlated with poor health status. Aging Cell 2009, 8:18-25.
35. Sasaki S., Sullivan M., Narvaez C.F., Holmes T.H., Furman D., Zheng N.Y., Nishtala M., Wrammert J., Smith K., James J.A., Dekker C.L., Davis M.M., Wilson P.C., Greenberg H.B., He X.S. Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies. J. Clin. Invest. 2011, 121:3109-3119.
36. McElhaney J.E., Xie D., Hager W.D., Barry M.B., Wang Y., Kleppinger A., Ewen C., Kane K.P., Bleackley R.C. T cell responses are better correlates of vaccine protection in the elderly. J. Immunol. 2006, 176:6333-6339.
37. Wang X., Chan C.C., Yang M., Deng J., Poon V.K., Leung V.H., Ko K.H., Zhou J., Yuen K.Y., Zheng B.J., Lu L. A critical role of IL-17 in modulating the B-cell response during H5N1 influenza virus infection. Cell. Mol. Immunol. 2011, 8:462-468.
38. Schwaiger S., Wolf A.M., Robatscher P., Jenewein B., Grubeck-Loebenstein B. IL-4-producing CD8+ T cells with a CD62L++(bright) phenotype accumulate in a subgroup of older adults and are associated with the maintenance of intact humoral immunity in old age. J. Immunol. 2003, 170:613-619.
39. Sallusto F., Geginat J., Lanzavecchia A. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu. Rev. Immunol. 2004, 22:745-763.
40. Kreijtz J.H., Fouchier R.A., Rimmelzwaan G.F. Immune responses to influenza virus infection. Virus Res. 2011, 162:19-30.